Cannabis for Rheumatic Disease Pain: Growing Interest, Limited Clinical Evidence
While interest in cannabis for rheumatic disease pain has surged and patients report benefits, the clinical literature remains heavily weighted toward reviews rather than original research, with very few randomized trials.
Quick Facts
What This Study Found
Publications on cannabis and rheumatic disease have increased, but recent literature skews heavily toward reviews over primary research. Survey studies show patients find cannabis beneficial, but prospective controlled trials remain rare.
Key Numbers
The review noted that the number of publications has increased but skews toward reviews rather than original research. Specific survey data showed increased cannabis use among people with rheumatic diseases.
How They Did This
Narrative review of current literature on cannabis for rheumatic disease pain, covering observational studies, surveys, and the limited randomized controlled trial data available through 2022.
Why This Research Matters
Rheumatic diseases cause chronic pain that is often difficult to manage. Patients are increasingly using cannabis on their own, so rheumatologists need to understand the current evidence (or lack thereof) to guide conversations with patients.
The Bigger Picture
This reflects a broader pattern in cannabis medicine: patient adoption has outpaced clinical evidence. The growing gap between what patients believe and what rigorous research has confirmed creates challenges for clinicians.
What This Study Doesn't Tell Us
This is a narrative review, not a systematic review with formal quality assessment. The conclusions are shaped by the absence of evidence (few RCTs exist) rather than evidence of absence.
Questions This Raises
- ?When will adequately powered RCTs on cannabis for rheumatic pain be completed?
- ?Which cannabinoid formulations and delivery methods are most promising for rheumatic conditions?
- ?How should rheumatologists counsel patients who are already using cannabis?
Trust & Context
- Key Stat:
- Literature skews heavily toward reviews vs. primary research
- Evidence Grade:
- Moderate: comprehensive narrative review from rheumatology experts, though limited by the scarcity of underlying RCT evidence.
- Study Age:
- Published in 2022.
- Original Title:
- Cannabis for Rheumatic Disease Pain: a Review of Current Literature.
- Published In:
- Current rheumatology reports, 24(5), 119-131 (2022)
- Database ID:
- RTHC-04107
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Does cannabis work for arthritis pain?
Patient surveys suggest many find it helpful, and preclinical data supports potential anti-inflammatory and analgesic effects. However, rigorous human trials are largely missing, so the clinical evidence remains weak.
What should rheumatology patients know about cannabis?
The review suggests that while the data is growing, it is not yet strong enough to make firm recommendations. Patients interested in cannabis should discuss it with their rheumatologist rather than self-treating.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-04107APA
Nowell, William Benjamin; Gavigan, Kelly; L Silverman, Stuart. (2022). Cannabis for Rheumatic Disease Pain: a Review of Current Literature.. Current rheumatology reports, 24(5), 119-131. https://doi.org/10.1007/s11926-022-01065-7
MLA
Nowell, William Benjamin, et al. "Cannabis for Rheumatic Disease Pain: a Review of Current Literature.." Current rheumatology reports, 2022. https://doi.org/10.1007/s11926-022-01065-7
RethinkTHC
RethinkTHC Research Database. "Cannabis for Rheumatic Disease Pain: a Review of Current Lit..." RTHC-04107. Retrieved from https://rethinkthc.com/research/nowell-2022-cannabis-for-rheumatic-disease
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.